Human Pluripotent Stem Cell Therapy for Huntington's Disease: Technical, Immunological, and Safety Challenges
- 1 October 2011
- journal article
- review article
- Published by Elsevier in Neurotherapeutics
- Vol. 8 (4), 562-576
- https://doi.org/10.1007/s13311-011-0079-4
Abstract
No abstract availableKeywords
This publication has 138 references indexed in Scilit:
- Dynamic Changes in the Copy Number of Pluripotency and Cell Proliferation Genes in Human ESCs and iPSCs during Reprogramming and Time in CultureCell Stem Cell, 2011
- Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNACell Stem Cell, 2010
- Epigenetic memory in induced pluripotent stem cellsNature, 2010
- Pax6 Is a Human Neuroectoderm Cell Fate DeterminantCell Stem Cell, 2010
- Long-Term, Stable Differentiation of Human Embryonic Stem Cell-Derived Neural Precursors Grafted into the Adult Mammalian NeostriatumThe International Journal of Cell Cloning, 2009
- Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming ProteinsCell Stem Cell, 2009
- Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signalingNature Biotechnology, 2009
- A patient with Huntington’s disease and long-surviving fetal neural transplants that developed mass lesionsActa Neuropathologica, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006